NCT06287541View on ClinicalTrials.gov

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

NARecruitingINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

July 1, 2027

Conditions
Non Muscle Invasive Bladder Cancer
Interventions
PROCEDURE

Urine biomarker -Guided without reTURBT

Participants will proceed without reTURBT

Trial Locations (1)

210029

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER